SwePub
Sök i LIBRIS databas

  Extended search

L773:2048 8734 OR L773:2048 8726
 

Search: L773:2048 8734 OR L773:2048 8726 > Survival after refr...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003219naa a2200325 4500
001oai:DiVA.org:uu-347426
003SwePub
008180402s2019 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3474262 URI
024a https://doi.org/10.1177/20488726187997452 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Schiller, Petteru Uppsala universitet,Thoraxkirurgi4 aut0 (Swepub:uu)pesch021
2451 0a Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score
264 c 2018-11-08
264 1b Oxford University Press (OUP),c 2019
338 a print2 rdacarrier
520 a Objectives: Survival after different short-term mechanical circulatory support is difficult to compare because various systems are used and patient disease severity is most often not adjusted for. This study compares the outcome after the use of Impella and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in refractory cardiogenic shock, adjusted for disease severity through the survival after the VA-ECMO (SAVE) score.Methods: Patients with refractory shock treated with either VA-ECMO or Impella between January 2003 and August 2015 were included. Data were analysed to assess short and long-term survival and complications. The SAVE score was calculated for the two groups and outcome was compared adjusted for the SAVE score.Results: There was no difference between VA-ECMO patients (n=46) and Impella patients (n=48) in mean age or renal failure. ECMO patients were more often intubated and had lower diastolic blood pressure at device implantation. ECMO patients had a lower SAVE score (–0.4 (6.5)) compared to Impella patients (4.1 (5.4)). There was no difference in intensive care unit survival between ECMO patients 65% (52–80) or Impella patients 63% (55–79), or long-term survival between groups. When stratified into worse (III–IV) or better SAVE class (I–II) there was no difference in survival between the groups.Conclusions: Short and long-term survival is not measurably different among patients treated with Impella or VA-ECMO due to refractory cardiogenic shock, after adjustment for disease severity through the SAVE score.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Hellgren, Lailau Uppsala universitet,Thoraxkirurgi4 aut0 (Swepub:uu)lahel172
700a Vikholm, Per,d 1985-u Uppsala universitet,Thoraxkirurgi4 aut0 (Swepub:uu)pervi242
710a Uppsala universitetb Thoraxkirurgi4 org
773t European Heart Journald : Oxford University Press (OUP)g 8:4, s. 329-337q 8:4<329-337x 2048-8726x 2048-8734
856u https://academic.oup.com/ehjacc/article-pdf/8/4/329/34174765/ehjacc0329.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-347426
8564 8u https://doi.org/10.1177/2048872618799745

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Schiller, Petter
Hellgren, Laila
Vikholm, Per, 19 ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cardiac and Card ...
Articles in the publication
European Heart J ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view